Anthropic and OpenEvidence Bring Medical AI to 100 Countries
New York, September 23, 2026: Artificial intelligence is moving deeper into global healthcare as AI company Anthropic and medical knowledge platform OpenEvidence partner to provide free AI-powered clinical decision support to doctors in around 100 low- and middle-income countries.
The initiative is designed for healthcare professionals who may have limited access to medical literature, specialist expertise and continuing medical education. According to information provided by OpenEvidence to Reuters, the rollout includes countries such as Uganda, Angola, Sudan, Haiti and Mongolia.
The partnership represents a growing effort to use artificial intelligence to reduce geographical differences in access to medical information. At the same time, the expansion highlights an important question for the healthcare industry: how can AI tools be introduced into clinical settings while maintaining appropriate evidence, safety and human oversight?
What Is OpenEvidence?
OpenEvidence is a medical knowledge platform designed to help doctors find answers to clinical questions
The platform draws on peer-reviewed medical research and treatment guidelines, allowing clinicians to search medical information while working with patients.
It is already available to clinicians in the United States and Europe. The new initiative extends a specialized version of the platform to healthcare providers in countries where access to medical information and specialist resources can be more limited.
The goal is not to replace doctors with AI.
Instead, the technology is intended to provide clinicians with additional information that can support medical decision-making.
Around 100 Countries Are Included
OpenEvidence said the initiative is being rolled out in approximately 100 countries.
The countries include locations across Africa, Asia and other regions where healthcare systems can face shortages of specialist expertise and medical resources.
Examples identified by OpenEvidence include Uganda, Angola, Sudan, Haiti and Mongolia.
The exact availability and implementation of the service can vary between countries as the technology is adapted to local healthcare conditions.
That localization is important because medical practice is not identical everywhere.
Disease patterns, available medicines, diagnostic equipment, healthcare infrastructure and treatment guidelines can differ significantly between countries.
Anthropic Will Provide the AI Technology
Under the partnership, Anthropic will provide the underlying AI technology while OpenEvidence adapts its clinical platform for different regions.
This means the two companies are combining general-purpose AI capabilities with a medical information system specifically designed for healthcare professionals.
Anthropic has separately identified global health as one of its areas of focus for beneficial AI deployment. The company says its health-related work includes supporting clinical decision-making and working with health organizations to improve access to healthcare information.
The companies have not disclosed financial terms for the partnership.
Why Medical Knowledge Access Matters
Doctors working in major medical centers can often access large medical libraries, specialist consultations, continuing education and advanced diagnostic resources.
Those resources may be harder to access in remote or under-resourced healthcare settings.
A doctor treating a complicated case may need to review medical literature or consult a specialist before deciding how to proceed.
AI-powered information systems could potentially make some of that knowledge easier to access.
For clinicians with a smartphone or computer and a suitable internet connection, an AI system can provide a searchable interface to large bodies of medical information.
That does not eliminate the need for doctors, but it can potentially make research and information retrieval faster.
AI Cannot Replace Clinical Judgment
The expansion of medical AI also comes with important limitations.
An AI system can provide information, summarize research and help clinicians explore possible answers, but medical decisions still require professional judgment.
Patient history, physical examination, laboratory results, imaging, local treatment availability and other clinical factors can influence the appropriate course of care.
AI systems can also produce incorrect or incomplete information.
For that reason, doctors need to verify important recommendations against reliable medical sources and their own clinical assessment.
The role of AI in healthcare is therefore increasingly being framed around decision support rather than autonomous decision-making.
Medical AI Still Needs Independent Evaluation
The rapid expansion of AI in medicine has also generated questions about how these systems should be evaluated.
A 2026 study published in Nature Medicine compared OpenEvidence and another specialized clinical AI system with several general-purpose frontier AI models across medical knowledge, clinician-alignment and real-world clinical-query tests.
The researchers reported that the general-purpose frontier models outperformed the specialized clinical AI tools across the evaluations they conducted. They also emphasized the need for independent and real-world assessment of AI systems before widespread clinical use.
The research does not determine whether the new Anthropic–OpenEvidence initiative will improve healthcare outcomes in the countries involved.
Instead, it illustrates why clinical AI needs continuing evaluation as it moves from technology demonstrations into real healthcare environments.
Local Adaptation Could Be Critical
One of the most important elements of the new initiative is regional adaptation.
A medical AI system designed primarily around healthcare in the United States or Europe may not automatically provide appropriate information for every other healthcare environment.
For example, a doctor may have access to different diagnostic tests, medicines or specialist services depending on where they work.
Disease prevalence can also vary substantially between regions.
OpenEvidence is therefore adapting the system to different healthcare environments rather than simply providing exactly the same experience everywhere.
This could become an important model for future global health AI systems.
Smartphones Could Help Expand Access
Another potential advantage of AI-based medical information systems is their ability to operate through widely available digital devices.
In regions where specialist medical resources are limited, smartphones can provide access to information without requiring a large physical medical library.
However, internet connectivity, electricity, device availability, language support and digital skills remain important practical considerations.
AI access alone cannot solve broader healthcare infrastructure problems.
A doctor still needs appropriate medicines, diagnostic equipment, trained colleagues and functioning healthcare facilities to provide effective patient care.
The Global Healthcare AI Market Is Growing
The Anthropic–OpenEvidence partnership also reflects a broader expansion of artificial intelligence into healthcare.
AI companies are developing systems for medical research, clinical documentation, diagnostic assistance, drug discovery and health administration.
Healthcare organizations are increasingly experimenting with these technologies as they search for ways to manage growing workloads and large volumes of medical information.
However, healthcare is a particularly sensitive area because mistakes can directly affect patients.
That makes transparency, evidence, privacy and human oversight especially important.
A Different AI Opportunity for Developing Countries
Much of the global AI conversation focuses on wealthy countries and major technology companies.
The new initiative highlights another potential use of AI: extending access to specialized knowledge in places where traditional resources may be limited.
If AI systems can be safely adapted to local conditions, they could potentially help healthcare workers access research and clinical information that would otherwise be difficult to obtain.
The actual impact will depend on how doctors use the tools and whether the systems perform reliably in different healthcare environments.
What Happens Next?
The rollout across approximately 100 countries will provide an opportunity to observe how medical AI performs outside the healthcare systems where many current AI tools were initially developed.
The companies will need to address questions involving accuracy, localization, connectivity, privacy and clinical oversight.
Healthcare organizations will also need ways to evaluate whether AI tools genuinely improve clinical workflows and patient care rather than simply adding another layer of technology.
Those questions are likely to become increasingly important as AI becomes a more common part of healthcare.
The Anthropic and OpenEvidence partnership demonstrates how artificial intelligence is beginning to move beyond consumer chatbots and business software into global healthcare systems.
Providing free clinical decision-support technology to doctors in around 100 countries could help reduce some barriers to accessing medical information. But the technology is not a substitute for trained healthcare professionals, reliable medical infrastructure or evidence-based clinical judgment.
The initiative also highlights a broader lesson for the global AI industry: building a powerful AI system is only one part of the challenge. Making that system useful, safe and appropriate for different communities is equally important.
As medical AI expands internationally, independent evaluation and responsible clinical use will remain central to determining its real-world value.
FlashNews24 will continue tracking major developments in artificial intelligence, healthcare technology and global innovation.
Get FlashNews24 App
Get breaking news, India news, World news, technology updates and more directly on your phone.
📱 GET THE APP